Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment response.
Letermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication.
Brazil is an ideal country in which to examine the health effects of climate change, and a new Brazilian study finds that females and children 0-4 years are among the most affected.